How to Cite: Meenakumari, M., & Girija, R. (2022). Synthesis of Bromo Aniline derivatives and an insilico approach against HSP90 chaperone. International Journal of Health Sciences, 6(S4), 11653–11667. https://doi.org/10.53730/ijhs.v6nS4.11260 International Journal of Health Sciences ISSN 2550-6978 E-ISSN 2550-696X © 2022. Manuscript submitted: 9 April 2022, Manuscript revised: 27 June 2022, Accepted for publication: 18 July 2022 11653 Synthesis of Bromo Aniline derivatives and an insilico approach against HSP90 chaperone M. Meenakumari* Research Scholar, Department of chemistry, Queen Mary’s college, Chennai, *Corresponding author R. Girija Assistant Professor Bio informatics infrastructure facility centre, Queen Mary’s college Abstract---Heterocyclic compounds are occupied in a huge variety of drugs which are widely distributed in nature and essential to life; Aniline has its remarkable influence in products that have been used by humans in day to day life. Its derivatives have made a remarkable trend over drug synthesis and this work shows the synthesis, characterization of some Bromo aniline derivatives and their action against the insilico docking studies against 4,5 Diaryl Isoxazole Hsp90 Chaperone Inhibitors a potential skin cancer therapeutic agent (2VCJ). Keywords---aniline, Bromo aniline derivatives, skin cancer, molecular docking studies. Introduction Heterocycles are an extraordinarily important class of compounds, making up more than half of all known organic compounds. They have been frequently found as a key structural unit in synthetic pharmaceuticals and agrochemicals[1]. Due to the broad application the review on aniline has attracted the attention of many researchers. It has increased its attention after the use of aniline as a byproduct in the synthesis of many chemicals. Therefore this work gives a broad view on aniline, its derivatives and their applications in various fields[2]. It covers the importance of Bromo substituted aniline derivatives. Molecular chaperones are proteins which play a key role in the conformational maturation, stability and function of other “client” protein substrates within the cell.[3-4] Hsp90 is important for stabilization and trafficking of tyrosine and serine/threonine kinases that are activated in response to genotoxic stress, including those that are essential for survival of cancer cells Some Hsp90 inhibitors are currently in phase I/II clinical trials in combination with IR or chemotherapeutic agents[5-7]